Penumbra Gross Profit 2014-2025 | PEN
Penumbra annual/quarterly gross profit history and growth rate from 2014 to 2025. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
- Penumbra gross profit for the quarter ending September 30, 2025 was $0.240B, a 20.02% increase year-over-year.
- Penumbra gross profit for the twelve months ending September 30, 2025 was $0.891B, a 21.85% increase year-over-year.
- Penumbra annual gross profit for 2024 was $0.755B, a 10.6% increase from 2023.
- Penumbra annual gross profit for 2023 was $0.683B, a 27.55% increase from 2022.
- Penumbra annual gross profit for 2022 was $0.535B, a 12.58% increase from 2021.
|
Penumbra Annual Gross Profit (Millions of US $) |
|
|---|---|
| 2024 | $755 |
| 2023 | $683 |
| 2022 | $535 |
| 2021 | $475 |
| 2020 | $338 |
| 2019 | $372 |
| 2018 | $293 |
| 2017 | $217 |
| 2016 | $171 |
| 2015 | $124 |
| 2014 | $83 |
| 2013 | $58 |
|
Penumbra Quarterly Gross Profit (Millions of US $) |
|
|---|---|
| 2025-09-30 | $240 |
| 2025-06-30 | $224 |
| 2025-03-31 | $216 |
| 2024-12-31 | $211 |
| 2024-09-30 | $200 |
| 2024-06-30 | $163 |
| 2024-03-31 | $181 |
| 2023-12-31 | $187 |
| 2023-09-30 | $178 |
| 2023-06-30 | $167 |
| 2023-03-31 | $151 |
| 2022-12-31 | $138 |
| 2022-09-30 | $135 |
| 2022-06-30 | $134 |
| 2022-03-31 | $127 |
| 2021-12-31 | $125 |
| 2021-09-30 | $120 |
| 2021-06-30 | $119 |
| 2021-03-31 | $111 |
| 2020-12-31 | $94 |
| 2020-09-30 | $91 |
| 2020-06-30 | $65 |
| 2020-03-31 | $88 |
| 2019-12-31 | $98 |
| 2019-09-30 | $96 |
| 2019-06-30 | $94 |
| 2019-03-31 | $84 |
| 2018-12-31 | $79 |
| 2018-09-30 | $75 |
| 2018-06-30 | $72 |
| 2018-03-31 | $67 |
| 2017-12-31 | $64 |
| 2017-09-30 | $55 |
| 2017-06-30 | $51 |
| 2017-03-31 | $48 |
| 2016-12-31 | $47 |
| 2016-09-30 | $43 |
| 2016-06-30 | $41 |
| 2016-03-31 | $40 |
| 2015-12-31 | $36 |
| 2015-09-30 | $33 |
| 2015-06-30 | $27 |
| 2015-03-31 | $27 |
| 2014-12-31 | |
| 2014-09-30 | $21 |
| 2013-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $11.546B | $1.195B |
| Penumbra, Inc. is an interventional therapies company. It designs, develops, manufactures and markets medical devices. The company's portfolio of products primarily addresses neuro and peripheral vascular medical conditions and clinical needs. Neuro products include Neurovascular Access, Neuron Access System, BENCHMARK Intracranial Access System, Penumbra System, 3D, Penumbra Coil 400, Penumbra SMART Coil and LIBERTY stent. Peripheral vascular products include Ruby Coil System, Penumbra Occlusion Device and Indigo System. It operates primarily in U.S., Europe, Canada and Australia. Penumbra, Inc. is headquartered in Alameda, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $213.481B | 25.37 |
| Intuitive Surgical (ISRG) | United States | $203.217B | 79.51 |
| IDEXX Laboratories (IDXX) | United States | $56.427B | 56.04 |
| Edwards Lifesciences (EW) | United States | $48.931B | 32.81 |
| Alcon (ALC) | Switzerland | $38.902B | 26.29 |
| IQVIA Holdings (IQV) | United States | $38.074B | 21.23 |
| Mettler-Toledo (MTD) | United States | $28.219B | 33.02 |
| STERIS (STE) | Ireland | $25.657B | 26.49 |
| DexCom (DXCM) | United States | $25.593B | 35.28 |
| Waters (WAT) | United States | $23.382B | 30.92 |
| Hologic (HOLX) | United States | $16.684B | 17.53 |
| SONOVA HOLDING (SONVY) | Switzerland | $14.692B | 0.00 |
| Globus Medical (GMED) | United States | $11.912B | 25.00 |
| Masimo (MASI) | United States | $7.566B | 24.24 |
| Glaukos (GKOS) | United States | $6.229B | 0.00 |
| Sysmex ADR (SSMXY) | Japan | $5.779B | 18.36 |
| Teleflex (TFX) | United States | $5.295B | 8.44 |
| TransMedics (TMDX) | United States | $4.668B | 55.30 |
| Veracyte (VCYT) | United States | $3.507B | 39.96 |
| LivaNova (LIVN) | United Kingdom | $3.422B | 18.49 |
| Alphatec Holdings (ATEC) | United States | $3.114B | 0.00 |
| Integer Holdings (ITGR) | United States | $2.422B | 11.37 |
| Elekta AB (EKTAY) | Sweden | $2.119B | 19.83 |
| Artivion (AORT) | United States | $2.088B | 95.80 |
| PROCEPT BioRobotics (PRCT) | United States | $1.902B | 0.00 |
| Nihon Kohden (NHNKY) | Japan | $1.738B | 15.17 |
| UFP Technologies (UFPT) | United States | $1.664B | 21.98 |
| AxoGen (AXGN) | United States | $1.420B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.406B | 0.00 |
| Beta Bionics (BBNX) | United States | $1.246B | 0.00 |
| IRadimed (IRMD) | United States | $1.215B | 57.87 |
| Integra LifeSciences Holdings (IART) | United States | $1.014B | 5.49 |
| OPKO Health (OPK) | United States | $1.013B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $0.914B | 0.00 |
| SiBone (SIBN) | United States | $0.824B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.700B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.620B | 36.04 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.619B | 0.00 |
| NeuroPace (NPCE) | United States | $0.547B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.546B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.522B | 10.41 |
| RxSight (RXST) | United States | $0.516B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.457B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.451B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.431B | 11.89 |
| ClearPoint Neuro (CLPT) | United States | $0.389B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.340B | 56.71 |
| Alpha Tau Medical (DRTS) | Israel | $0.330B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.302B | 2.26 |
| Spectral Diagnostics (EDTXF) | Canada | $0.280B | 0.00 |
| Nano-X Imaging (NNOX) | Israel | $0.244B | 0.00 |
| 908 Devices (MASS) | United States | $0.242B | 0.00 |
| CVRx (CVRX) | United States | $0.236B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.197B | 0.00 |
| Inogen (INGN) | United States | $0.181B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.176B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.166B | 0.00 |
| Solana (HSDT) | United States | $0.162B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.158B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.145B | 0.00 |
| LENSAR (LNSR) | United States | $0.134B | 0.00 |
| Accuray (ARAY) | United States | $0.112B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.105B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.101B | 0.00 |
| Hyperfine (HYPR) | United States | $0.100B | 0.00 |
| Neuronetics (STIM) | United States | $0.089B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.087B | 0.00 |
| DarioHealth (DRIO) | United States | $0.082B | 0.00 |
| InspireMD (NSPR) | United States | $0.077B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.074B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.062B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.055B | 0.00 | |
| Spectral AI (MDAI) | United States | $0.052B | 0.00 |
| Precision Optics (POCI) | United States | $0.032B | 0.00 |
| Envoy Medical (COCH) | United States | $0.024B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.019B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.016B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.014B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.013B | 0.00 |
| Check-Cap (MBAI) | Israel | $0.012B | 0.00 |
| NexGel (NXGL) | United States | $0.012B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.012B | 0.00 |
| PAVmed (PAVM) | United States | $0.010B | 0.00 |
| Tenon Medical (TNON) | United States | $0.010B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.007B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.006B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.005B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.005B | 0.00 |
| Nuwellis (NUWE) | United States | $0.005B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 10.98 |